To clarify the specific molecular mechanism of FTO regulating the FAK signaling pathway and identify its downstream targets in NSCLC, a human m6A epitranscriptomic microarray was performed to map the m6A modifications in NSCLC. Here, PTK2 is linked to non-small cell lung carcinoma.